untitled design

AstraZeneca Vaccine: First case of thrombosis in South Korea

South Korea today reported the first case of the rare thrombosis associated with its vaccine AstraZeneca against covid, reports APE.

This is a man in his 30s, who was vaccinated on April 27 while working in a health facility, according to the director of the Korean Office of Disease Control and Prevention (KDCA) Jeong Eun-kyeong.

The man suffered a headache on May 9 and sought medical attention before being admitted to hospital on May 12 as the headache continued and he also suffered muscle cramps, Jeong noted.

“His condition has improved since then and we understand that there is no big problem although he still needs to be monitored,” she added.

Jeong explained that the symptoms are curable if detected in time and treated properly.

AstraZeneca Vaccine: Approximately 3.27 Million People Have One Dose – What the Company Says About Thrombosis Cases

Some 3.27 million people in South Korea have been vaccinated with at least one dose of the AstraZeneca vaccine so far.

Reports worldwide of extremely rare cases of thrombosis, especially the so-called cerebral venous thrombosis (CVST), which is observed in combination with low platelets, ie thrombocytopenia.

Medical regulators in the US and Europe have reported that there appears to be a link between the AstraZeneca vaccine and that of AstraZeneca. Johnson & Johnson, but that vaccines are safe and the benefits outweigh the risks.

AstraZeneca has said it is working to understand individual cases and “possible mechanisms that could explain these extremely rare cases”, while J&J said no clear causal link had been found between the vaccine and the clots.

South Korea has restricted the use of the AstraZeneca vaccine in people over the age of 30 following reports of blood clots.

The KDCA reported 430 new cases of coronavirus yesterday with a total of 140,340 cases and 1,959 deaths.

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular